3-(2,2,2-trimethylhydrazine)propionate has been researched along with betaine in 14 studies
| Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (betaine) | Trials (betaine) | Recent Studies (post-2010) (betaine) |
|---|---|---|---|---|---|
| 251 | 35 | 105 | 4,213 | 198 | 1,878 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clouet, P; Demarquoy, J; Galland, S; Guyonnet, D; Le Borgne, F | 1 |
| Baumane, L; Boucher, JL; Dzintare, M; Kalvinsh, I; Lauberte, L; Meirena, D; Sjakste, J; Sjakste, N | 1 |
| Baumane, L; Boucher, JL; Dzintare, M; Kalvinsh, I; Kleschyov, AL; Meirena, D; Münzel, T; Sjakste, J; Sjakste, N; Sydow, K | 1 |
| Dambrova, M; Kalvinsh, I; Kirjanova, O; Liepinsh, E; Loca, D; Pugovichs, O; Vilskersts, R | 1 |
| Belozertseva, I; Cirule, H; Dambrova, M; Kalvinsh, I; Liepinsh, E; Pugovichs, O; Svalbe, B; Zorenko, T; Zvejniece, L | 1 |
| Cirule, H; Dambrova, M; Kalvinsh, I; Kuka, J; Liepinsh, E; Pugovics, O; Skapare, E; Svalbe, B; Vilskersts, R | 2 |
| Chlopicki, S; Dambrova, M; Grinberga, S; Kalvinsh, I; Liepinsh, E; Mateuszuk, L; Vilskersts, R | 1 |
| Dambrova, M; Liepinsh, E; Muceniece, R; Pugovics, O; Svalbe, B; Vavers, E; Zvejniece, L | 1 |
| Dambrova, M; Grinberga, S; Kalvinsh, I; Konrade, I; Kuka, J; Liepinsh, E; Pugovics, O; Skapare, E | 1 |
| Cirule, H; Dambrova, M; Kalvinsh, I; Kuka, J; Liepinsh, E; Makrecka, M; Pugovics, O; Vilskersts, R | 1 |
| Cirule, H; Dambrova, M; Grinberga, S; Mezhapuke, R; Vilskersts, R; Zharkova-Malkova, O | 1 |
| Cirule, H; Dambrova, M; Grinberga, S; Gustina, D; Kuka, J; Liepins, J; Liepinsh, E; Loza, E; Makrecka-Kuka, M; Pugovics, O; Zharkova-Malkova, O | 1 |
| Cirule, H; Dambrova, M; Grinberga, S; Hartmane, D; Liepinsh, E; Makarova, E; Sevostjanovs, E; Zharkova-Malkova, O | 1 |
1 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and betaine
| Article | Year |
|---|---|
Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers.
Topics: Adult; Betaine; Cardiovascular Agents; Carnitine; Diet; Female; Humans; Male; Meat; Methylhydrazines; Middle Aged; Young Adult | 2011 |
13 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and betaine
| Article | Year |
|---|---|
Purification and characterization of the rat liver gamma-butyrobetaine hydroxylase.
Topics: Animals; Ascorbic Acid; Betaine; Carnitine; Catalase; Catalysis; Chromatography, Affinity; Enzyme Inhibitors; Ferrous Compounds; gamma-Butyrobetaine Dioxygenase; Hydroxylation; Ketoglutaric Acids; Kinetics; Ligands; Liver; Male; Methylhydrazines; Mixed Function Oxygenases; Molecular Weight; Rats; Rats, Wistar | 1998 |
Effects of gamma-butyrobetaine and mildronate on nitric oxide production in lipopolysaccharide-treated rats.
Topics: Adjuvants, Immunologic; Animals; Betaine; Carnitine; Lipopolysaccharides; Male; Methylhydrazines; Nitric Oxide; Rats; Rats, Wistar; Sepsis | 2004 |
Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: possible link to the antiischemic activities of mildronate.
Topics: Animals; Aorta, Thoracic; Betaine; Carnitine; Ditiocarb; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Electron Spin Resonance Spectroscopy; Endothelium; Male; Methylhydrazines; Muscle, Smooth, Vascular; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Vasodilation | 2004 |
Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
Topics: Animals; Betaine; Cardiovascular Agents; Carnitine; Chromatography, High Pressure Liquid; Coronary Circulation; gamma-Butyrobetaine Dioxygenase; In Vitro Techniques; Injections, Intraperitoneal; Male; Methylhydrazines; Myocardial Infarction; Myocardium; Rats; Rats, Wistar | 2006 |
Effect of inhibiting carnitine biosynthesis on male rat sexual performance.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Behavior, Animal; Betaine; Carnitine; Chromatography, Liquid; Chymases; Dose-Response Relationship, Drug; Male; Methylhydrazines; Rats; Sexual Behavior, Animal; Sperm Motility; Spermatozoa; Tandem Mass Spectrometry; Testosterone; Time Factors | 2008 |
Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart.
Topics: Animals; Betaine; C-Peptide; Carnitine; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Heart; Hexokinase; Male; Methylhydrazines; Mice; Mice, Inbred ICR; Myocardium; RNA, Messenger; Up-Regulation | 2008 |
Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice.
Topics: Animals; Aorta; Atherosclerosis; Betaine; Cardiovascular Agents; Carnitine; Energy Metabolism; Female; Lipids; Male; Methylhydrazines; Mice; Mice, Knockout; Rats; Rats, Wistar | 2009 |
Effects of long-term mildronate treatment on cardiac and liver functions in rats.
Topics: Animals; Betaine; Biomarkers; Blood Glucose; Body Weight; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dose-Response Relationship, Drug; Glucose; Heart; Hemodynamics; Lipids; Liver; Liver Glycogen; Male; Methylhydrazines; Myocardium; Rats; Rats, Wistar; Time Factors; Toxicity Tests, Chronic | 2009 |
Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats.
Topics: Adjuvants, Immunologic; Analysis of Variance; Animals; Betaine; Brain Infarction; Carnitine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Extremities; Infarction, Middle Cerebral Artery; Locomotion; Male; Methylhydrazines; Psychomotor Performance; Rats; Rats, Wistar; Recovery of Function; Rotarod Performance Test; Tandem Mass Spectrometry; Vibrissae | 2011 |
The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine.
Topics: Animals; Betaine; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Chromatography, Liquid; Drug Interactions; Fatty Acids; Male; Methylhydrazines; Mitochondria, Heart; Mitochondrial Membranes; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Tandem Mass Spectrometry; Vitamin B Complex | 2012 |
Elevated vascular γ-butyrobetaine levels attenuate the development of high glucose-induced endothelial dysfunction.
Topics: Animals; Aorta; Betaine; Cardiovascular Agents; Carnitine; Drug Therapy, Combination; Endothelium, Vascular; Glucose; Male; Methylhydrazines; Rats; Rats, Wistar | 2013 |
Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Topics: Animals; Betaine; Biosynthetic Pathways; Carbon Isotopes; Carnitine; Choline; Chromatography, High Pressure Liquid; Gastrointestinal Tract; Methylamines; Methylhydrazines; Microbiota; Rats; Rats, Wistar; Statistics, Nonparametric; Tandem Mass Spectrometry | 2014 |
Carnitine and γ-Butyrobetaine Stimulate Elimination of Meldonium due to Competition for OCTN2-mediated Transport.
Topics: Animals; Betaine; Biological Transport; Carnitine; Furosemide; Male; Methylhydrazines; Mice; Organic Cation Transport Proteins; Solute Carrier Family 22 Member 5; Tissue Distribution | 2017 |